Drugs / PEP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04664738 | Mar 2021 → Aug 2023 | — | Rion Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04664738 ↗ |
| Modality | Other / unclassified | “PEP is comprised of platelet derived extracellular vesicles enriched in anti-inflammatory and angiogenic growth factors.” NCT04664738 ↗ |